Concepedia

Christopher E. Rudd

CE

Statistics

Publications

145

Citations

12.6K

H-Index

63

Active since

1979

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

University of Cambridge

Hôpital Maisonneuve-Rosemont

Hammersmith Hospital

Christopher E. Rudd is an author at Dana-Farber Cancer Institute specializing in life sciences, immunology, and cell signaling.

ORCID

Publications per year

1979–2024

145

Publications

145

The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes.

Christopher E. Rudd, James M. Trevillyan, J D Dasgupta et al. · Proceedings of the National Academy of Sciences · 1988 · 720 citations · Full text

, , +13

CEACAM1 regulates TIM-3-mediated tolerance and exhaustion

Yu‐Hwa Huang, Chen Zhu, Yasuyuki Kondo et al. · Nature · 2014 · 719 citations

, , +12

Reversal of the TCR Stop Signal by CTLA-4

Helga Schneider, Jos Downey, Andrew Smith et al. · Science · 2006 · 605 citations

, , +17

The CD28-Related Molecule ICOS Is Required for Effective T Cell–Dependent Immune Responses

Anthony J. Coyle, Sophie M. Lehar, Clare M. Lloyd et al. · Immunity · 2000 · 513 citations · Full text

, , +12

The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex.

Elizabeth K. Barber, J D Dasgupta, Stuart F. Schlossman et al. · Proceedings of the National Academy of Sciences · 1989 · 456 citations · Full text

, , +14

1–5 of 145